Literature DB >> 2502396

Down-regulation of alpha 3(VI) chain expression by gamma-interferon decreases synthesis and deposition of collagen type VI.

M Heckmann1, M Aumailley, A Hatamochi, M L Chu, R Timpl, T Krieg.   

Abstract

Treatment of cultured human skin fibroblasts with increasing doses of gamma-interferon produces a distinct reduction of steady-state levels of the alpha 3 chain of collagen VI mRNA by about 60% but not of the alpha 1 and alpha 2 chain mRNAs. A similar decrease was also observed for collagen I and III mRNA while fibronectin mRNA remained at the same level. The decrease in alpha 3(VI) mRNA is accompanied by a reduced synthesis of collagen VI and by a reduced deposition of both collagen VI and fibronectin in urea-insoluble form in the cell matrix. No other gamma-interferon effects were observed for fibronectin biosynthesis. Immunoprecipitation of metabolically labeled collagen VI demonstrated a strongly reduced synthesis (by 65-80%) of intracellular alpha 3(VI) chains with no decrease found for alpha 1(VI) and alpha 2(VI) chains. All three chains were, however, found to be reduced in the culture medium. Pepsin treatment of immunoprecipitated collagen VI showed similar chain ratios for material in the culture medium obtained in the absence or presence of gamma-interferon. It indicates that correctly assembled heterotrimers of the composition [alpha 1(VI) alpha 2(VI) alpha 3(VI)] are formed and secreted also in the absence of an equivalent alpha 3(VI) chain synthesis but at a reduced rate. The data support previous predictions from sequence analyses [Chu et al. (1988) J. Biol. Chem. 263, 18,601-18,606] that collagen VI molecules composed of all three constituent chains are more stable than other assembly alternatives.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502396     DOI: 10.1111/j.1432-1033.1989.tb14884.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Molecular composition of type VI collagen. Evidence for chain heterogeneity in mammalian tissues and cultured cells.

Authors:  C M Kielty; R P Boot-Handford; S Ayad; C A Shuttleworth; M E Grant
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  Drs criswell and sack respond.

Authors:  L A Criswell; K E Sack
Journal:  West J Med       Date:  1991-02

3.  Tryptophan-induced eosinophilia-myalgia syndrome.

Authors:  L A Criswell; K E Sack
Journal:  West J Med       Date:  1990-09

4.  Altered procollagen mRNA expression during the progression of avian scleroderma.

Authors:  M J Ausserlechner; R Sgonc; H Dietrich; G Wick
Journal:  Mol Med       Date:  1997-10       Impact factor: 6.354

5.  Inhibition of collagen expression by azelastine hydrochloride in cultured skin fibroblasts from normal individuals and scleroderma patients.

Authors:  H Yamada; S Tajima
Journal:  Arch Dermatol Res       Date:  1996-09       Impact factor: 3.017

6.  Hyperglycemic glucose concentrations up-regulate the expression of type VI collagen in vitro. Relevance to alterations of peripheral nerves in diabetes mellitus.

Authors:  P Muona; S Jaakkola; R Z Zhang; T C Pan; L Pelliniemi; L Risteli; M L Chu; J Uitto; J Peltonen
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  Effects of tumor necrosis factor-alpha on connective tissue metabolism in normal and scleroderma fibroblast cultures.

Authors:  K Takeda; A Hatamochi; M Arakawa; H Ueki
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

8.  Mosaic structure of globular domains in the human type VI collagen alpha 3 chain: similarity to von Willebrand factor, fibronectin, actin, salivary proteins and aprotinin type protease inhibitors.

Authors:  M L Chu; R Z Zhang; T C Pan; D Stokes; D Conway; H J Kuo; R Glanville; U Mayer; K Mann; R Deutzmann
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.